State NJ
Clinical Trials in New Jersey
New Jersey is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in New Jersey and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in New Jersey
Frequently Asked Questions — Clinical Trials in New Jersey
How many clinical trials are currently recruiting in New Jersey?
ClinicalMetric currently tracks 237 actively recruiting clinical trials with at least one location in New Jersey. The total number of registered studies—including active but not currently enrolling trials—is 237. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in New Jersey?
New Jersey hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Multiple Myeloma, Pancreatic Ductal Adenocarcinoma, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout New Jersey serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in New Jersey?
To join a clinical trial in New Jersey, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in New Jersey maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in New Jersey
NCT07221474 Phase 2
Recruiting
A Study of Intismeran Autogene (V940)/Placebo + Pembrolizumab and Chemotherapy i...
Condition
Squamous Non-small Cell Lung Cancer
Enrollment
180 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT03351348 Phase 3
Recruiting
Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pa...
Condition
Breast Cancer
Enrollment
165 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT05562791 Phase 1
Recruiting
A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin Can...
Condition
Bladder Cancer
Enrollment
20 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT06033248 N/A
Recruiting
Using Urine Samples to Identify Lung Cancer
Condition
Non Small Cell Lung Cancer
Enrollment
210 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT07198074 Phase 3
Recruiting
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Ca...
Condition
Advanced Endometrial Carcinoma
Enrollment
255 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT06557148 N/A
Recruiting
A Study Comparing Cancer Imaging Approaches in People With Lobular Breast Cancer
Condition
Breast Cancer
Enrollment
30 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT04865887 Phase 2
Recruiting
Pembrolizumab and Lenvatinib in Advanced Cervical Cancer
Condition
Cervical Cancer
Enrollment
35 pts
Location
United States
Sponsor
Georgetown University
NCT03184038 N/A
Recruiting
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurg...
Condition
Metastatic Malignant Neoplasm in the Brain
Enrollment
90 pts
Location
United States
Sponsor
Sidney Kimmel Comprehensive Ca
NCT06072378 N/A
Recruiting
The Computational and Neural Mechanisms Linking Decision-making and Memory in Hu...
Condition
Memory, Short-Term
Enrollment
50 pts
Location
United States
Sponsor
Rutgers, The State University
NCT06695884 N/A
Recruiting
Identify the Optimal TMS Pulse Protocol to Modulate Reward Activity
Condition
Nicotine Use Disorder
Enrollment
42 pts
Location
United States
Sponsor
Rutgers, The State University
NCT05267626 Phase 1, Phase 2
Recruiting
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Bi...
Condition
Advanced Solid Tumor
Enrollment
159 pts
Location
United States, Australia
Sponsor
Aulos Bioscience, Inc.
NCT05725499 N/A
Recruiting
The Effect of Transcutaneous Stimulation on Blood Pressure in Spinal Cord Injury...
Condition
Spinal Cord Injuries
Enrollment
5 pts
Location
United States
Sponsor
Kessler Foundation
NCT07226609 N/A
Recruiting
A Dietary Study for People With Multiple Myeloma
Condition
Multiple Myeloma
Enrollment
220 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT07000084 Phase 3
Recruiting
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BC...
Condition
Recurrent Non-Muscle Invasive Bladder Carcinoma
Enrollment
330 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT05850234 Phase 1, Phase 2
Recruiting
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
Condition
Relapsed/Refractory Multiple Myeloma
Enrollment
182 pts
Location
United States
Sponsor
AstraZeneca
NCT06473987 N/A
Recruiting
Personalized Cognitive Integrated Motor Training Using Virtual Reality to Improv...
Condition
Traumatic Brain Injury
Enrollment
135 pts
Location
United States
Sponsor
Kessler Foundation
NCT06577441 Phase 2
Recruiting
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedaz...
Condition
Myelodysplastic Syndrome
Enrollment
54 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT07221877 Phase 4
Recruiting
A Study to Evaluate the Effect of KarXT on Urological Safety
Condition
Schizophrenia
Enrollment
60 pts
Location
United States
Sponsor
Bristol-Myers Squibb
NCT03460977 Phase 1
Recruiting
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration R...
Condition
Metastatic Castration Resistant Prostate Cancer (mCRPC)
Enrollment
453 pts
Location
United States, Bulgaria, China
Sponsor
Pfizer
NCT06278207 N/A
Recruiting
An Observational Study Called FINEROD to Learn More About the Use of the Treatme...
Condition
Chronic Kidney Disease
Enrollment
50,000 pts
Location
United States, Germany, Japan
Sponsor
Bayer
NCT06072131 Phase 3
Recruiting
To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP A...
Condition
Peripheral T Cell Lymphoma
Enrollment
504 pts
Location
United States, Canada, Germany
Sponsor
Acrotech Biopharma Inc.
NCT07011719 Phase 3
Recruiting
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients...
Condition
Metastatic Clear Cell Renal Cell Carcinoma
Enrollment
720 pts
Location
United States, Australia, Canada
Sponsor
Arcus Biosciences, Inc.
NCT05651945 N/A
Recruiting
Cardiac Rehabilitation of Stroke Survivors (SRP-CROSS)
Condition
Stroke
Enrollment
150 pts
Location
United States
Sponsor
Hackensack Meridian Health
NCT03911700 N/A
Recruiting
Prophylactic Reinforcement of Ventral Abdominal Incisions Trial
Condition
Open Midline Laparotomy
Enrollment
477 pts
Location
United States, Austria, Belgium
Sponsor
C. R. Bard
NCT07326566 Phase 2
Recruiting
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM...
Condition
Glioblastoma (GBM)
Enrollment
162 pts
Location
United States
Sponsor
Black Diamond Therapeutics, In
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology